Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver

Cell Death and Differentiation

Volumn 22, Issue 5, 2015, Pages 790-800

  Haas, N ^a   Riedt, T ^a   Labbaf, Z ^a   Bassler K ^a   Gergis, D ^a   Frohlich H ^a   Gutgemann I ^a   Janzen, V ^a   Schorle, H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STEM CELL FACTOR RECEPTOR;

ANIMAL; APOPTOSIS; CELL CULTURE; CYTOLOGY; ERYTHROBLAST; FETUS; GENETICS; HUMAN; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ERYTHROBLASTS; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETUS; HUMANS; LIVER; MAP KINASE SIGNALING SYSTEM; MICE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ERYTHROPOIETIN;

EID: 84939991630     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.172     Document Type: Article

References (62)

1. Ogawa M, Nishikawa S, Yoshinaga K, Hayashi S, Kunisada T, Nakao J et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kitindependent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development 1993; 117: 1089-1098.
2. De Jong MO, Westerman Y, Wagemaker G, Wognum AW. Coexpression of Kit and the receptors for erythropoietin, interleukin 6 and GM-CSF on hemopoietic cells. Stem Cells 1997; 15: 275-285.
3. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83: 59-67.
4. De Aberle SB. A study of the hereditary anaemia of mice. Am J Anat 1927; 40: 219-249.
5. Pircher TJ, Geiger JN, Zhang D, Miller CP, Gaines P, Wojchowski DM. Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 2001; 276: 8995-9002.
6. Tan BL, Hong L, Munugalavadla V, Kapur R. Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 2003; 278: 11686-11695.
7. Sui X, Krantz SB, You M, Zhao Z. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood 1998; 92: 1142-1149.
8. Muta K, Krantz SB, Bondurant MC, Dai CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995; 86: 572-580.
9. Geslain R, Uddin S, Liu H, Jiang H, van Besien K, Pan T et al. Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors. Cytokine 2013; 61: 329-335.
10. Muta K, Krantz SB, Bondurant MC, Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 1994; 94: 34-43.
11. Miura Y, Miura O, Ihle JN, Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 1994; 269: 29962-29969.
12. Klingmüller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC et al. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 1997; 94: 3016-3021.
13. Arcasoy MO, Jiang X. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor. Br J Haematol 2005; 130: 121-129.
14. Linnekin D, Deberry CS, Chem JB, Mou S. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J Biol Chem 1997; 272: 27450-27455.
15. Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, Rönnstrand L. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene 1999; 18: 5546-5553.
16. Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P et al. Lyn kinase plays important roles in erythroid expansion, maturation and Epo-receptor signaling by regulating inhibitory signaling pathways that control survival. Biochem J 2014; 459: 455-466.
17. Remy I, Wilson IA, Michnick SW. Erythropoietin receptor activation by a ligand-induced conformation change. Science 1999; 283: 990-993.
18. Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997; 89: 3636-3643.
19. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677-689.
20. Dubois NC, Adolphe C, Ehninger A, Wang R a, Robertson EJ, Trumpp A. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 2008; 135: 2455-2465.
21. Gregory T, Yu C, Ma a, Orkin SH, Blobel G a, Weiss MJ. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 1999; 94: 87-96.
22. Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 1994; 8: 1184-1197.
23. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA 1996; 93: 12355-12358.
24. Hall MA, Curtis DJ, Metcalf D, Elefanty AG, Sourris K, Robb L et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100: 992-997.
25. Xiang Z, Kreisel F, Cain J, Colson A, Tomasson MH. Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling. Mol Cell Biol 2007; 27: 267-282.
26. Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804-815.
27. Malaise M, Steinbach D, Corbacioglu S. Clinical implications of c-Kit mutations in acute myelogenous leukemia. Curr Hematol Malig Rep 2009; 4: 77-82.
28. De Felipe P, Ryan MD. Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 2004; 5: 616-626.
29. Hayashi S, Lewis P, Pevny L, McMahon AP. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech Dev 2002; 119(Suppl): S97-S101.
30. De Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 2003; 33: 314-325.
31. Goossens S, Janzen V, Bartunkova S, Yokomizo T, Drogat B, Crisan M et al. The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. Blood 2011; 117: 5620-5630.
32. Zhang J, Socolovsky M, Gross AW, Lodish HF. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 2003; 102: 3938-3946.
33. Pop R, Shearstone JR, Shen Q, Liu Y, Hallstrom K, Koulnis M et al. A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression. PLoS Biol 2010; 8: 1-19.
34. Sprüssel A, Schulte JH, Weber S, Necke M, Händschke K, Thor T et al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 2012; 26: 2039-2051.
35. Von Lindern M, Deiner EM, Dolznig H, Parren-Van Amelsvoort M, Hayman MJ, Mullner EW et al. Leukemic transformation of normal murine erythroid progenitors: v-and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene 2001; 20: 3651-3664.
36. Carotta S, Pilat S, Mairhofer A, Schmidt U, Dolznig H, Steinlein P et al. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood 2004; 104: 1873-1880.
37. Sathyanarayana P, Dev A, Fang J, Houde E, Bogacheva O, Bogachev O et al. EPO receptor circuits for primary erythroblast survival. Blood 2008; 111: 5390-5399.
38. Asano H, Fukunaga S, Deguchi Y, Kawamura S, Inaba M. Bcl-xL and Mcl-1 are involved in prevention of in vitro apoptosis in rat late-stage erythroblasts derived from bone marrow. J Toxicol Sci 2012; 37: 23-31.
39. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008; 454: 232-235.
40. Aerbajinai W, Giattina M, Lee YT, Raffeld M, Miller JL. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. Blood 2003; 102: 712-717.
41. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997; 89: 3148-3154.
42. Jegalian AG, Wu H. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J Biol Chem 2002; 277: 2345-2352.
43. Kapur R, Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem 2001; 276: 1099-1106.
44. Van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Löwenberg B, von Lindern M. Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 2000; 96: 3406-3413.
45. Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY et al. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 2006; 66: 473-481.
46. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 2000; 20: 9018-9027.
47. Jayapal SR, Lee KL, Ji P, Kaldis P, Lim B, Lodish HF. Down-regulation of Myc is essential for terminal erythroid maturation. J Biol Chem 2010; 285: 40252-40265.
48. Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EV. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 1988; 8: 884-892.
49. Briegel K, Lim KC, Plank C, Beug H, Engel JD, Zenke M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormonedependent manner. Genes Dev 1993; 7: 1097-1109.
50. Bartunek P, Králová J, Blendinger G, Dvorák M, Zenke M. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 2003; 22: 1927-1935.
51. Rylski M, Welch JJ, Chen Y-Y, Letting DL, Diehl JA, Chodosh LA et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 2003; 23: 5031-5042.
52. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domainwide chromatin remodeling. Proc Natl Acad Sci USA 2003; 100: 8811-8816.
53. Zeuner a, Francescangeli F, Signore M, Venneri M a, Pedini F, Felli N et al. The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis. Cell Death Differ 2011; 18: 371-380.
54. Zeuner A, Pedini F, Signore M, Testa U, Pelosi E, Peschle C et al. Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. Blood 2003; 102: 87-93.
55. Bouscary D, Pene F, Claessens Y-E, Muller O, Chrétien S, Fontenay-Roupie M et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 2003; 101: 3436-3443.
56. Hong L, Ramdas B, Chen J, Harris C, Wojchowski DM, Kapur R. KIT associated intracellular tyrosines play an essential role in EpoR co-signaling. Cell Signal 2008; 20: 1513-1520.
57. Gerbaulet A, Wickenhauser C, Scholten J, Peschke K, Drube S, Horny H-P et al. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit. Blood 2011; 117: 2012-2021.
58. Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MAS, Besmer P. Kit receptor gain-offunction in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells 2013; 31: 1683-1695.
59. Oh P, Lobry C, Gao J, Tikhonova A, Loizou E, Manent J et al. In vivo mapping of notch pathway activity in normal and stress hematopoiesis. Cell Stem Cell 2013; 13: 190-204.
60. Moenning A, Jäger R, Egert A, Kress W, Wardelmann E, Schorle H. Sustained plateletderived growth factor receptor alpha signaling in osteoblasts results in craniosynostosis by overactivating the phospholipase C-gamma pathway. Mol Cell Biol 2009; 29: 881-891.
61. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
62. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza M-L, Jeanny J-C, Dannenberg J-H et al. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 1998; 12: 1599-1609.